Received May 8, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNP | MENINGOCOCCAL CONJUGATE (PENMENVY) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 3S9XZ | — |
Inadvertent administration of only the liquid portion; Inadvertent administration of only the liquid portion; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ABCWY NVS (Penmenvy) (batch number 3S9XZ) for prophylaxis. On 27-APR-2026, the patient received Penmenvy. On 27-APR-2026, an unknown time after receiving Penmenvy, the patient experienced inappropriate preparation of medication (Verbatim: Inadvertent administration of only the liquid portion) and inappropriate dose of vaccine administered (Verbatim: Inadvertent administration of only the liquid portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:29-APR-2026 The administration Facility is the same as Primary Reporter.